|
Moreno MJ, Lozano ML, Roldán V, Bellosillo B, García-Barberá N, Rivera J, Navarro-Núñez L, Besses C, Vicente V, Martínez C. JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia. Ann Hematol. 2008 Sep;87(9):763-5. doi: 10.1007/s00277-008-0474-z. Epub 2008 Mar 26. PubMed PMID: 18365193.
AÑO: 2008; IF: 2.454
|
18365193
|
Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial. J Clin Oncol. 2007 Jan 1;25(1):16-24. PubMed PMID: 17194902.
AÑO: 2007; IF: 15.484
|
|
Ortuño FJ, Castilla C, Moreno MJ, del Mar Osma M, Gonzalez M, Vicente V. Erythrophagocytosis in de novo-philadelphia-positive acute leukemia of ambiguous lineage. Haematologica. 2006 Aug;91(8 Suppl):ECR43. PubMed PMID: 16923527.
AÑO: 2006; IF: 5.032
|